manufacturing problems — e.g. “Problemi produttivi” (Italy)
Recent shortage history
Spain: resolved 5 Mar 2026 (began 16 Dec 2025)
Spain: resolved 14 Apr 2026 (began 30 Sept 2025)
Spain: resolved 11 Sept 2025 (began 7 Aug 2025)
Spain: resolved 26 Oct 2025 (began 27 May 2025)
Italy: resolved 4 Mar 2022 (began 4 Mar 2022)
Frequently asked questions
Is Levobupivacaina Cloridrato currently in shortage?
Yes. As of the latest regulator updates, Levobupivacaina Cloridrato has 2 active shortage notices across 1 country (Italy). Status is refreshed daily from official regulatory sources.
Why is Levobupivacaina Cloridrato in shortage?
Regulators attribute the current Levobupivacaina Cloridrato shortages to manufacturing problems. The exact cause varies by country and product — each notice on this page links to the official source.
When will the Levobupivacaina Cloridrato shortage be resolved?
Regulator-estimated resolution dates currently range from 31 Dec 2026 to 31 Dec 2026, depending on country and product. These estimates come from the manufacturers via regulators and often change — check the per-country table above for the latest.
Where does this Levobupivacaina Cloridrato shortage data come from?
Every shortage notice on this page is scraped daily from an official national medicines regulator (such as the FDA, TGA, MHRA or EMA) and linked back to its source. Mederti aggregates 40+ regulators across 50+ countries and never publishes unsourced shortage claims.
Get alerted when Levobupivacaina Cloridrato status changes
Free for individual pharmacists and clinicians — watchlists, email alerts, alternatives and country-by-country product detail.
Data on this page is aggregated from official national medicines regulators and updated daily. It is provided for information only and requires verification before clinical use. Mederti is not affiliated with or endorsed by any regulator.